A detailed history of Ulysses Management LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Ulysses Management LLC holds 21,500 shares of XBI stock, worth $1.99 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
21,500
Previous 17,500 22.86%
Holding current value
$1.99 Million
Previous $1.62 Million 30.95%
% of portfolio
0.2%
Previous 0.23%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$90.87 - $102.43 $363,480 - $409,720
4,000 Added 22.86%
21,500 $2.12 Million
Q1 2024

May 15, 2024

BUY
$87.05 - $102.89 $1.13 Million - $1.34 Million
13,000 Added 288.89%
17,500 $1.66 Million
Q4 2023

Feb 14, 2024

BUY
$64.12 - $90.86 $288,540 - $408,870
4,500 New
4,500 $401,000
Q2 2023

Aug 14, 2023

SELL
$75.38 - $90.23 $188,450 - $225,575
-2,500 Reduced 14.29%
15,000 $1.25 Million
Q1 2023

May 15, 2023

BUY
$73.13 - $91.97 $43,878 - $55,182
600 Added 3.55%
17,500 $1.33 Million
Q4 2022

Feb 14, 2023

BUY
$76.72 - $85.66 $912,968 - $1.02 Million
11,900 Added 238.0%
16,900 $1.4 Million
Q3 2022

Nov 14, 2022

BUY
$75.06 - $94.9 $375,300 - $474,500
5,000 New
5,000 $397,000

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Ulysses Management LLC Portfolio

Follow Ulysses Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ulysses Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ulysses Management LLC with notifications on news.